Cellibre is a series a startup based in United States. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
Cellibre is a synthetic biology company that employs an organism-agnostic approach to turn cells into specialized, sustainable factories for the manufacture of ingredients and products.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky